Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 1, 2002, Pages 5-15

  Wang, Yang ^a   Guo, Yiru ^a   Zhang, Shelley X ^a   Wu, Wen Jian ^a   Wang, Jianxun ^a   Bao, Weike ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Gene expression; Infarction; Ischemia; Mouse; Myocardium

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; MESSENGER RNA; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY REPERFUSION; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME REGULATION; FIBROBLAST; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; RNA ANALYSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0036169559     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1482     Document Type: Article

References (52)

1. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. A "second window of protection" or delayed preconditioning phenomenon: Future horizons for myocardial protection?
3. The late phase of preconditioning
4. Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning
5. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning
6. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits
7. Ischemicpreconditioningincreases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism
8. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
9. A(1) or A(3) adenosine receptors induce latepreconditioningagainst infarction in conscious rabbits by different mechanisms
10. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: Evidence from gene-knockout mice
11. Delayed or second window preconditioning induced by adenosine A1 receptor activation is independent of early generation of nitric oxide or late induction of inducible nitric oxide synthase
12. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: Evidence from pharmacological inhibition and gene knockout mice
13. Nitric oxide and cardiac function
14. Nitric oxide: Pathophysiological mechanisms
15. The L-arginine-nitric oxide pathway
16. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility
17. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and micro-vascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha
18. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines
19. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction
20. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction
21. Inducible nitric oxide synthase gene transcription and protein activity in the rat heart during endotoxaemia
22. Demonstration of an early and a late phase of ischemic preconditioning in mice
23. Cloned and expressed macrophage nitric oxide synthane contrasts with the brain enzyme
24. Cloning and characterization of murine endothelial constitutive nitric oxide synthane
25. Inducible nitric oxide synthase: What difference does it make?
26. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
27. Induction of myocardial nitric oxide synthase by cardiac allograft rejection
28. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: Insights from NOS2-knockout mice
29. Altered immune responses in mice lacking inducible nitric oxide synthase
30. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection
31. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
32. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
33. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics
34. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene
35. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia
36. Nitric oxide synthases: Gene structure and regulation
37. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites
38. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways
39. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase
40. Li JJ, Bolli R
41. An essential role of the JAK-STAT pathway in ischemic preconditioning
42. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide
43. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon gamma and lipopolysaccharide
44. Requirement for transcription factor IRF-1 in NO synthane induction in macrophages
45. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes
46. Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthane induction in vascular smooth muscle cells
47. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells
48. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
49. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes
50. Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts
51. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
52. TPA and cycloheximide modulate the activation of NF-kappa B and the induction and stability of nitric oxide synthase transcript in primary neonatal rat hepatocytes